Privium Fund Management (Uk) LTD Sio Gene Therapies Inc. Transaction History

Privium Fund Management (Uk) LTD

  • $252 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
BUY
$1.29 - $2.36 $2.33 Million - $4.26 Million
1,806,542 New
1,806,542 $2.37 Million

Others Institutions Holding SIOX

# of Institutions
2
Shares Held
147K
Call Options Held
0
Put Options Held
0
View Full List

About Sio Gene Therapies Inc.

SIOX Quotes by TradingView
  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Privium Fund Management (Uk) LTD Portfolio

Follow Privium Fund Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email